Discovery of potent and selective 5-azaindazole inhibitors of leucine-rich repeat kinase 2 (LRRK2) - Part 1. (2019)

First Author: Osborne J
Attributed to:  Understanding Signalling Pathways Mutated in Inherited Disorders funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.bmcl.2018.11.058

PubMed Identifier: 30554956

Publication URI: http://europepmc.org/abstract/MED/30554956

Type: Journal Article/Review

Volume: 29

Parent Publication: Bioorganic & medicinal chemistry letters

Issue: 4

ISSN: 0960-894X